More than two-thirds of all U.S. states are experiencing “high” or “very high” levels of COVID-19, data published by the Centers for Disease Control and Prevention (CDC) show.
States with very high levels of COVID-19, according to the CDC, include California, Nevada, Oregon, Washington, Idaho, Utah, New Mexico, Texas, Wyoming, Colorado, Louisiana, Arkansas, Missouri, Minnesota, Florida, South Carolina, Maryland, Massachusetts, and New Hampshire.
High levels of COVID-19 have been reported in Alaska, Hawaii, Montana, Oklahoma, Kansas, Wisconsin, Kentucky, Tennessee, Mississippi, Alabama, Georgia, North Carolina, Virginia, West Virginia, Delaware, Connecticut, and Maine, according to the agency.
Only one state—New York—is reporting “low” levels of COVID-19, the CDC map shows. All the other states are seeing “moderate” levels. No data were provided for Arizona, North Dakota, and U.S. territories, including the U.S. Virgin Islands, Guam, and Puerto Rico.
During a previous increase in COVID-19 in the winter of 2023–24, about 2,000 deaths were being reported on a weekly basis. And in the winter of 2020–21, upward of 25,000 COVID-related deaths were tallied each week, according to the CDC data.
Andy Pekosz, a molecular microbiology professor at Johns Hopkins University, said the KP.3 variant doesn’t appear to cause more severe symptoms. Antibodies provided through prior infection or vaccines have led to better outcomes in recent months, he said in an interview posted on the university’s website in May.
In June, CDC spokesman David Daigle told The Epoch Times that “there is currently no evidence that LB.1 causes more severe disease” and that “most key COVID-19 indicators are showing low levels of activity nationally, therefore the total number of infections this lineage may be causing is likely low.”
“CDC will continue to track SARS-CoV-2 variants and is working to better understand the potential impact on public health,” he said, referring to the virus that causes COVID-19.
An advisory panel for the Food and Drug Administration stated in June that vaccine makers should now target any COVID-19 variants that are derived from JN.1. Those vaccines should be rolled out in the fall of 2024, officials said.
Weeks later, CDC Director Mandy Cohen recommended updated COVID-19 and influenza vaccines.